title: The Heart Outcomes Prevention Evaluation (HOPE)-3 trial: where do we stand?
authors.affiliation: aSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece bDepartment of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK cFirst Department of Cardiology, National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Costas
authors.initials: C
authors.lastname: Tsioufis
mesh_terms: D000959:Antihypertensive Agents / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D006801:Humans
chemical_list: D000959:Antihypertensive Agents